Windtree Therapeutics Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Out of Business

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 28

  • Investments
  • 6

Windtree Therapeutics General Information

Description

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

Contact Information

Formerly Known As
Ansan, Ansan Pharmaceuticals, Discovery Laboratories
Ownership Status
Out of Business
Financing Status
Corporation
Corporate Office
  • 2600 Kelly Road
  • Suite 100
  • Warrington, PA 18976-3622
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Former Stock Listing
WINT
Corporate Office
  • 2600 Kelly Road
  • Suite 100
  • Warrington, PA 18976-3622
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Windtree Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Windtree Therapeutics‘s full profile, request access.

Request a free trial

Windtree Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical co
Biotechnology
Warrington, PA
29 As of 2025

South San Francisco, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Windtree Therapeutics Competitors (18)

One of Windtree Therapeutics’s 18 competitors is Tenaya Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tenaya Therapeutics Formerly VC-backed South San Francisco, CA
Avalyn Pharma Formerly VC-backed Boston, MA
Savara Formerly VC-backed Yardley, PA
Aqualung Therapeutics Venture Capital-Backed Tucson, AZ
Verve Therapeutics Formerly VC-backed Boston, MA
You’re viewing 5 of 18 competitors. Get the full list »

Windtree Therapeutics Patents

Windtree Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024399423-A1 Istaroxime and metabolite derivatives thereof for reducing the risk of acute myocardial arrhythmia Pending 11-Dec-2023
EP-4823583-A1 Istaroxime and metabolite derivatives thereof for reducing the risk of acute myocardial arrhythmia Pending 11-Dec-2023
WO-2025128432-A1 Istaroxime and metabolite derivatives thereof for reducing the risk of acute myocardial arrhythmia Inactive 11-Dec-2023
EP-4634177-A1 Solid forms of {5-cyclopropyl-2-[2-(3,6-difluoro- pyridin-2-ylamino)-pyridin-4-yl]-pyrido[3,4-d]pyrimidin-4-yl}-((s)-3,3-dimethyl-piperidin-4-yl)-amine Pending 13-Dec-2022
JP-2026500270-A Solid forms of {5-cyclopropyl-2-[2-(3,6-difluoro-pyridin-2-ylamino)-pyridin-4-yl]-pyrido[3,4-d]pyrimidin-4-yl}-((s)-3,3-dimethyl-piperidin-4-yl)-amine Pending 13-Dec-2022 C07D471/04
To view Windtree Therapeutics’s complete patent history, request access »

Windtree Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Windtree Therapeutics Investments & Acquisitions (6)

Windtree Therapeutics’s most recent deal was a Corporate Asset Purchase with Windtree Therapeutics (436 Unit Multifamily Residential Property in Houston, Texas) for . The deal was made on 01-May-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Windtree Therapeutics (436 Unit Multifamily Residential Property in Houston, Texas) 01-May-2025 Corporate Asset Purchase Buildings and Property
Varian Biopharmaceuticals 02-Apr-2024 Merger/Acquisition Drug Discovery
KatKin 08-Aug-2022 Early Stage VC Other Consumer Non-Durables
CVie Therapeutics Company 21-Dec-2018 Merger/Acquisition Drug Discovery
AEROSURF 15-Oct-2014 Joint Venture Managed Care
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Windtree Therapeutics FAQs

  • When was Windtree Therapeutics founded?

    Windtree Therapeutics was founded in 1992.

  • Where is Windtree Therapeutics headquartered?

    Windtree Therapeutics is headquartered in Warrington, PA.

  • What is the size of Windtree Therapeutics?

    Windtree Therapeutics has 29 total employees.

  • What industry is Windtree Therapeutics in?

    Windtree Therapeutics’s primary industry is Biotechnology.

  • Is Windtree Therapeutics a private or public company?

    Windtree Therapeutics is a Private company.

  • What is Windtree Therapeutics’s current revenue?

    The current revenue for Windtree Therapeutics is .

  • How much funding has Windtree Therapeutics raised over time?

    Windtree Therapeutics has raised $633M.

  • Who are Windtree Therapeutics’s competitors?

    Tenaya Therapeutics, Avalyn Pharma, Savara, Aqualung Therapeutics, and Verve Therapeutics are some of the 18 competitors of Windtree Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process